Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy: A Case Study
NCT ID: NCT05325047
Last Updated: 2023-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6 participants
INTERVENTIONAL
2022-09-20
2023-05-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective is to demonstrate the efficacy of preoperative speech therapy on language performance and to evaluate possible protective effects on postoperative language prognosis.
Single case study following the Single Case Experimental Design (SCED) methodology involving the prior definition of the following elements: a repeated measure of the target behavior (naming abilities), the sequential introduction of an intervention (speech therapy), whose effect will be evaluated according to SCED specific analysis and statistics (visual analysis, Tau -U, randomized tests).
Investigators expect patients' naming performance to be stable before the introduction of speech therapy. It is expected that patients will progress in the trained words from the beginning of speech therapy. Finally, in the postoperative period, investigators predict that for the trained words, patients will show performances superior or equal to the pre-rehabilitation period. This result would support a protective effect of preoperative speech therapy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intensive Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy
NCT05609084
Cortical Resections in Drug Resistant Epilepsy
NCT04553354
Surgery as a Treatment for Medically Intractable Epilepsy
NCT01273129
Minimally Invasive Surgical Epilepsy Trial for Temporal Lobe Epilepsy
NCT05019404
Cognitive Impact of Benzodiazepin Withdrawn After Curative Epilepsy Surgery in Children With Focal Epilepsy
NCT03803046
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Speech rehabilitation
Intensive speech rehabilitation
Combination an e-health device allowing the patient to self-rehabilitate with a face-to-face approach of accompaniment and support of the patient by the speech therapist.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intensive speech rehabilitation
Combination an e-health device allowing the patient to self-rehabilitate with a face-to-face approach of accompaniment and support of the patient by the speech therapist.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with signed informed consent,
* Patient whose epileptogenic area involves the temporal structures of the hemisphere specialized for language,
* Patient with known hemispheric specialization for language (fMRI),
* Patient who is a surgical candidate and accepts resective surgery,
* Patient for whom a surgery date compatible with the study design has been set;
* Patient of French nationality and mother tongue (1st language learned by the patient),
* Patient affiliated to or benefiting from a social security system,
* Patient declaring to be familiar with the use of a computer and having access to an Internet connection from home.
Exclusion Criteria
* Patients deprived of liberty,
* Patients under guardianship or curatorship
* Patients with speech disorders that may impair intelligibility and compromise the use of the interface,
* Patients with uncorrected hearing impairment,
* Patients with low overall intellectual functioning: total intelligence quotient (IQ) \<70 (data from the preoperative neuropsychological assessment performed in the year preceding the surgery)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François CREMIEUX
Role: STUDY_DIRECTOR
APHM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Bordeaux
Bordeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID-RCB
Identifier Type: OTHER
Identifier Source: secondary_id
2021-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.